Home Trade Closing Bell 4-8-19 PHAS +36.4% (receives FDA Breakthrough Therapy
  Previous Video 4-8-19 SOXX Index 1500 put options Daily, Weekly Charts over bought
  Next Video 4-8-19 Earnings Season Big profits starts this week

4-8-19 PHAS +36.4% (receives FDA Breakthrough Therapy

0
0
0

4-8-19 PHAS +36.4% (receives FDA Breakthrough Therapy

Companies trading higher in after hours in reaction to news: PHAS +36.4% (receives FDA Breakthrough Therapy designation for PB2452 for the reversal of the antiplatelet; provided immediate and sustained reversal of ticagrelor antiplatelet effects in ph I trial),

LEAVE YOUR COMMENT

Your email address will not be published. Required fields are marked *

Translate »
cycloneslider-slide